Archival of Human Biological Samples in CU-Med Biobank
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Specimen Collection.
- Who it may be relevant to
- Registry conditions: Healthy, Cancer, Heart Diseases, Neurological Diseases or Conditions. Basic parameters: No limits · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Hong Kong
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Overview
CU-Med Biobank collaborates with different researchers for collecting and distributing human biospecimens and clinical data for assisting scientific research.
Detailed description
CU-Med Biobank will collect and store high-quality specimens from cancer-related or other diseases. All samples are linked to annotated clinical data from approved consented protocols. This system provides researchers with high- quality biological samples and comprehensive clinical, pathological including molecular/genetic information for their research. This standardized CU-Med Biobank is a pivotal bridge to improve the translation of basic research into clinical applications. These findings will contribute to improve prevention, enhance diagnosis, develop new treatment and eventual cure of diseases.
Interventions
- Procedure Specimen Collection
Specimens obtained from surgical, phlebotomy or other non-invasive procedure
Primary outcome measures
- To distribute human biospecimens for clinical research [Time frame: 99 years]
- To discover the pathological mechanism of different acute and chronic diseases such as cancer, stroke, heart disease, dementia & diabetes [Time frame: 99 years]
Eligibility criteria
Inclusion criteria
- Enrolled subjects that have provided signed consent for the specimens and de-identified data to be collected, stored and distributed.
Exclusion criteria
- Subjects without signed informed consent for the specimens and de-identified data to be collected, stored and distributed.
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: Yes
Study design
- Observational model
- Cohort
Study locations
Hong Kong · 1 center
- CU-Med Biobank — Hong Kong
Identifiers
NCT: NCT04706481 · CREC 2019.152